BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 26032111)

  • 21. Multiple Step-section Frozen Section sentinel lymph node biopsy--a review of 717 patients.
    Lim J; Govindarajulu S; Sahu A; Ibrahim N; Magdub S; Cawthorn S
    Breast; 2013 Oct; 22(5):639-42. PubMed ID: 23953247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction score model for non-sentinel and four or more nodal metastases using a combined method of one-step nucleic acid amplification and histology in sentinel node-positive breast cancer patients.
    Jimbo K; Kinoshita T; Ogura T; Watase C; Murata T; Shiino S; Takayama S; Yoshida M
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):516-521. PubMed ID: 31711717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic review and economic evaluation of intraoperative tests [RD-100i one-step nucleic acid amplification (OSNA) system and Metasin test] for detecting sentinel lymph node metastases in breast cancer.
    Huxley N; Jones-Hughes T; Coelho H; Snowsill T; Cooper C; Meng Y; Hyde C; Mújica-Mota R
    Health Technol Assess; 2015 Jan; 19(2):v-xxv, 1-215. PubMed ID: 25586547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nomogram to predict non-sentinel lymph node status using total tumor load determined by one-step nucleic acid amplification: first report from Thailand.
    Sa-Nguanraksa D; O-Charoenrat E; Kulprom A; Samarnthai N; Lohsiriwat V; Nimpoonsri K; O-Charoenrat P
    Breast Cancer; 2019 Jul; 26(4):471-477. PubMed ID: 30617675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
    Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F
    Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
    Tvedskov TF
    Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraoperative analysis of sentinel lymph nodes in breast cancer by one-step nucleic acid amplification.
    Cserni G
    J Clin Pathol; 2012 Mar; 65(3):193-9. PubMed ID: 22090341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel lymph node micrometastasis as a predictor of axillary tumor burden.
    Dabbs DJ; Fung M; Landsittel D; McManus K; Johnson R
    Breast J; 2004; 10(2):101-5. PubMed ID: 15009035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Routine clinical use of the one-step nucleic acid amplification assay for detection of sentinel lymph node metastases in breast cancer patients: results of a multicenter study in Japan.
    Tamaki Y; Sato N; Homma K; Takabatake D; Nishimura R; Tsujimoto M; Yoshidome K; Tsuda H; Kinoshita T; Kato H; Taniyama K; Kamio T; Nakamura S; Akiyama F; Noguchi S;
    Cancer; 2012 Jul; 118(14):3477-83. PubMed ID: 22252672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraoperative assessment of sentinel lymph node by one-step nucleic acid amplification in breast cancer patients after neoadjuvant treatment reduces the need for a second surgery for axillary lymph node dissection.
    Espinosa-Bravo M; Navarro-Cecilia J; Ramos Boyero M; Diaz-Botero S; Dueñas Rodríguez B; Luque López C; Ramos Grande T; Ruano Perez R; Peg V; Rubio IT
    Breast; 2017 Feb; 31():40-45. PubMed ID: 27810698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reliability of whole sentinel lymph node analysis by one-step nucleic acid amplification for intraoperative diagnosis of breast cancer metastases.
    Castellano I; Macrì L; Deambrogio C; Balmativola D; Bussone R; Ala A; Coluccia C; Sapino A
    Ann Surg; 2012 Feb; 255(2):334-42. PubMed ID: 21975319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative molecular analysis of sentinel lymph node may be predictive of axillary node status in breast cancer classified by molecular subtypes.
    Buglioni S; Di Filippo F; Terrenato I; Casini B; Gallo E; Marandino F; Maini CL; Pasqualoni R; Botti C; Di Filippo S; Pescarmona E; Mottolese M
    PLoS One; 2013; 8(3):e58823. PubMed ID: 23533593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene promoter hypermethylation is found in sentinel lymph nodes of breast cancer patients, in samples identified as positive by one-step nucleic acid amplification of cytokeratin 19 mRNA.
    Martín-Sánchez E; Pernaut-Leza E; Mendaza S; Cordoba A; Vicente-Garcia F; Monreal-Santesteban I; Vizcaino JP; De Cerio MJ; Perez-Janices N; Blanco-Luquin I; Escors D; Ulazia-Garmendia A; Guerrero-Setas D
    Virchows Arch; 2016 Jul; 469(1):51-9. PubMed ID: 27097811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-sentinel lymph node analysis with one-step nucleic acid amplification in breast cancer patients.
    Ogiya A; Iwase T; Kitagawa D; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F
    Breast; 2015 Aug; 24(4):476-80. PubMed ID: 25963136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of analysis of the sentinel lymph node by one-step nucleic acid amplification (OSNA) compared to conventional histopathology on axillary and systemic treatment: data from the Dutch nationwide cohort of breast cancer patients.
    van Haaren ERM; Poodt IGM; Spiekerman van Weezelenburg MA; van Bastelaar J; Janssen A; de Vries B; Lobbes MBI; Bouwman LH; Vissers YLJ
    Breast Cancer Res Treat; 2023 Nov; 202(2):245-255. PubMed ID: 37495799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
    Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
    J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative analysis of axillary nodal burden in ultrasound/biopsy positive axilla vs ultrasound negative sentinel lymph node biopsy positive axilla.
    Tandon M; Ball W; Kirby R; Soumian S; Narayanan S
    Breast Dis; 2019; 38(3-4):93-96. PubMed ID: 30909179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of sentinel lymph node biopsy prior to axillary lymph node dissection: the role of isolated tumor cells/micrometastases and multifocality/multicentricity-a retrospective study of 1214 breast cancer patients.
    Schröder L; Fricker R; Stein RG; Rink T; Fitz H; Blasius S; Wöckel A; Müller T
    Arch Gynecol Obstet; 2018 Jun; 297(6):1509-1515. PubMed ID: 29594495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.